BPC-157 Explained: What the Research Shows (Philippines Guide)

A 2025 review of BPC-157 in sports medicine included 36 studies. Only one of them was in humans. So what do we actually know? BPC-157 is a synthetic peptide made of 15 amino acids.

It is derived from a protein found in human gastric juice, which is why researchers call it a gastric pentadecapeptide. The leading idea is angiogenesis, the growth of new blood vessels into damaged tissue. Lab studies also report more growth hormone receptors on cells. A 2003 rat study in the Journal of Orthopaedic Research found faster healing of cut Achilles tendons.

The 2025 review found animal studies reporting better outcomes across muscle, tendon, ligament and bone injuries. The single human study was a small retrospective report, not a controlled trial. 7 of 12 people with chronic knee pain reported relief lasting over 6 months. In people, almost everything.

The review found no human safety data, and warned about contamination and unknown safety in unregulated products. BPC-157 is not approved as a medicine by any regulator. It is on the World Anti-Doping Agency prohibited list. In the US, the FDA listed it in 2023 as a compounding substance with safety concerns, including immunogenicity.

That listing was withdrawn in April 2026, and a July 2026 advisory vote is not a final decision. If you are sourcing research peptides in the Philippines, Primara Labs publishes independent lab reports you can verify yourself. Guides at primaralabs.com.